Document is current
Any future updates will be listed below
-
Authors
Vergara, Itziar http://orcid.org/0000-0001-9671-7898
Mateo-Abad, Maider
Saucedo-Figueredo, María Carmen
Machón, Mónica
Montiel-Luque, Alonso
Vrotsou, Kalliopi
Nava del Val, María Antonia
Díez-Ruiz, Ana
Güell, Carolina
Matheu, Ander
Bueno, Antonio
Núñez, Jazmina
Rivas-Ruiz, Francisco
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI14/01003, PI14/01905)
European Regional Development Fund (RD06/001/0000, RD06/0001/1009)
Eusko Jaurlaritza (2016222043)
Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza (kk-2016/00106)
- License Information
-
More Information
Article History
Received: 27 December 2018
Accepted: 11 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: This work was authorized by the corresponding Ethics Committees (Comité de Ética de la Investigación con medicamentos de Euskadi 01/2015; Comité de Ética de Investigación Costa del Sol n° exp. 11Nov2014 PR Fragilidad). All participants provided informed written consent.
: Not applicable.
: The authors declare that they no competing interests.
